Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02624193 · ClinicalTrials.gov registry record · NA
Health Improvement for Baltimore Youth
A NA study of HIV and Medication Adherence, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 97
- Enrollment target
- 2
- Study locations
NCT02624193: Completed NA study of HIV and Medication Adherence, sponsored by Johns Hopkins University.
NCT02624193 is a NA study of HIV and Medication Adherence that has completed, run by Johns Hopkins University. The registered enrollment target is 97 participants, below the 440-participant average among 303 other HIV trials with a reported enrollment target (78% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02624193, a NA study of HIV and Medication Adherence, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 97 participants
- Enrollment target
- 2
- Study locations
Study Summary
Preliminary data from the investigators' National Center for Complementary and Alternative Medicine (NCCAM)-funded R21 on mindfulness-based stress reduction (MBSR) in HIV-infected youth suggest an association between mindfulness and improved self-regulation and medication adherence. This randomized, controlled trial will help the investigators to better understand the specific impact of MBSR on HIV medication and treatment adherence in HIV-infected youth, and the efficacy of MBSR in the amelioration of stress and improved self-regulation.
Primary Outcome
Assessment of impact of MBSR versus HT on treatment adherence as measured by the Adolescent Medicine Trials Network (ATN) HIV Medication Adherence self-report measure, as well as CD4 and viral load counts pulled from the participant's medical record. The measure and medical record data collection takes place at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up.
Conditions Studied
Interventions
- BEHAVIORAL MBSR Program
- BEHAVIORAL HT Program
Study Locations (2)
Maryland
- University of Maryland Medical Center - Baltimore
- Johns Hopkins Harriet Lane Clinic - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 97 participants |
| Start Date | 2013-04 |
| Est. Completion | 2018-06-25 |
| Phase | NA |
What the finished NCT02624193 record still lists
NCT02624193 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 97 participants, a relatively small participant target, below the 440-participant average among 303 other HIV trials with a reported enrollment target (78% lower).
The record links to 4 conditions, with HIV appearing as the primary indexed condition, and to 2 interventions - of which MBSR Program is the first listed.
NCT02624193 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT02624193 about?
NCT02624193 is a clinical study titled "Health Improvement for Baltimore Youth". Preliminary data from the investigators' National Center for Complementary and Alternative Medicine (NCCAM)-funded R21 on mindfulness-based stress reduction (MBSR) in HIV-infected youth suggest an association between mindfulness and improved self-regulation and medication adherence. This randomized,...
What is the current status of trial NCT02624193?
This trial is currently completed. It is a NA study. The enrollment target is 97 participants. The study started on 2013-04. Estimated completion is 2018-06-25.
What conditions does trial NCT02624193 study?
This clinical trial studies the following conditions: HIV, Medication Adherence, Adolescent Behavior, Adolescent Development.
What interventions are being tested in trial NCT02624193?
The interventions under investigation include: MBSR Program (BEHAVIORAL), HT Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT02624193?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02624193 being conducted?
This trial has 2 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02624193's enrollment target sits among peer trials
97 163rd of 303 higher than 140 of 303 other HIV trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
RECRUITING · NA
-
Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Assessing Peer Support for Physical Activity in Women With HIV and Hypertension
RECRUITING · NA
-
Open Trial of Trauma-focused Psychodynamic Psychotherapy for People Living With HIV and PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03948490 · 97 participants · NA
Rehabilitation and Longitudinal Follow-up of Cognition in Adult Lower Grade Gliomas
- NCT04140487 · 97 participants · Phase 1
Azacitidine, Venetoclax, and Gilteritinib in Treating Patients With Recurrent/Refractory FLT3-Mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Myeloproliferative Neoplasm
- NCT04196413 · 97 participants · Phase 1
GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas (DIPG) & Spinal Diffuse Midline Glioma(DMG)
- NCT05223816 · 97 participants · Phase 2
An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia